Hepatitis C Virus
New research on hepatitis C virus from V. Soriano and co-authors summarized
Published in Hepatitis Weekly, February 23rd, 2009
"Serious adverse effects and limited sustained virological responses with this therapy warrant the need for novel HCV therapies. Specifically targeted antiviral therapies designed to inhibit the HCV serine protease and the RNA-dependent RNA polymerase have recently entered clinical development," wrote V. Soriano and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2009-02-23)
More Articles from Hepatitis Weekly
- Cold Spring Harbor Laboratory
Camouflaging of viral DNA could be crucial step in progression of cancers - Aethlon Medical, Inc.
Aethlon Medical Announces Expansion Into the Infectious Disease Diagnostic Market - Cancer Vaccines
Study findings on cancer vaccines are outlined in reports from Stanford University - Hepatitis B Virus
Scientists at University of Barcelona release new data on hepatitis B virus - Hepatitis C Virus
Data on hepatitis C virus described by researchers at Kurume University, Medical Department - Hepatitis C Virus
Findings in hepatitis C virus reported from B.N. Gross and co-researchers - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
